Table II.
Patient characteristics by GERD status and timing of LARS
| GERD (−) | GERD (+) No LARS | Early LARS | Late LARS | P value | |
|---|---|---|---|---|---|
| Number of patients | 12 | 8 | 9 | 10 | – |
| Age (years) | 59 (53–63) | 62 (54–66) | 55 (37–59) | 48 (32–55) | .018 |
| Female gender (%) | 8 (67) | 4 (50) | 5 (56) | 3 (30) | .276 |
| Transplant indication (%) | .322 | ||||
| CF | 1 | 1 | 2 | 3 | |
| COPD | 8 | 4 | 2 | 2 | |
| IPF | 3 | 1 | 1 | 4 | |
| AATD | 0 | 1 | 2 | 1 | |
| BOOP | 0 | 0 | 1 | 0 | |
| Jo-1 Syndrome | 0 | 1 | 0 | 0 | |
| PF from Pneumoconiosis | 0 | 0 | 1 | 0 | |
| Transplant type (%) | .538 | ||||
| Right single | 3 | 1 | 2 | 1 | |
| Left single | 5 | 2 | 2 | 1 | |
| Bilateral | 3 | 4 | 2 | 8 | |
| Re-transplant | 1 | 1 | 3 | 0 | |
| Follow-up (months) | 18 (16–24) | 17 (11–23) | 14 (12–22) | 22 (17–47) | .185 |
| BOS ≥1 at 1 yr (%) | 1 (33) | 1 (33) | 1 (33) | 0 | .651 |
Data presented as median (interquartile range).
AATD, Alpha-1 Antitrypsin deficiency; BOOP, bronchiolitis obliterans organizing pneumonia; BOS, bronchiolitis obliterans syndrome; CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; GERD, gastroesophageal reflux disease; IPF, idiopathic pulmonary fibrosis; LARS, laparoscopic antireflux surgery; PF, pulmonary fibrosis.